1. Introduction
===============

In the recent paper in the resistance to fluoroquinolones by the combination of target site mutations and enhanced expression of genes for efflux pumps in *Shigella flexneri* [@B001], we presented that MdfA could be related to fluoroquinolone resistance.

The most common example of an major facilitator superfamily (MFS) antibiotic efflux system in gramnegative bacteria is that encoded by the various *tet* genes associated with tetracycline efflux and resistance [@B002]. Members of this family of efflux fluoroquinolones are, by contrast, rare in gram-negative bacteria and include only the MdfA transporter of *Escherichia coli* [@B003],[@B004]. Therefore, we would like to report the additional evidences that the MdfA is related to fluoroquinolone resistance in *S flexneri*, even though MdfA does appear to be a more effective pump for nonantibiotics. However, the increased expression level of the MdfA efflux pump mediating fluoroquinolone resistance was first confirmed in the *Shigella* species strains in this study [@B001],[@B002]. This study demonstrated that resistance to fluoroquinolone is due to efflux by theMdfA system in the *Shigella* species. To determine the molecular basis of efflux in the *Shigella* species, a deletion mutation in *mdfA* was constructed.

###### 

MICs of S flexneri SF021787 and SF021895 isolates

  ---------------------- ---------------------------------------- ------------ ------------ ------- ------------ ------
  Strains                Substitution in *gyrA* and *parC* QRDR   MIC(μg/ml)                                     
                                                                                                                 
  *gyrA*                 *parC*                                   CIP          CIP + CCCP   NOR     NOR + CCCP   
                                                                                                                 
  SF021787               S83L                                     S80I, R91Q   16           0.125   32           0.25
  SF021787Δ*mdfA::kan*   S83L                                     S80I, R91Q   12                   4            
                                                                                                                 
  SF021895               S83L, D87G                               S80I, R91Q   16           0.125   8            0.25
  SF021895Δ*mdfA::kan*   S83L, D87G                               S80I, R91Q   12                   4            
  ---------------------- ---------------------------------------- ------------ ------------ ------- ------------ ------

2. Methods
==========

Deletion of the *mdfA* gene was performed by the method described by Datsenko and Wanner [@B005]. The kanamycin resistance gene kan flanked by flippase (FLP) recognition target sites was amplified by a standard polymerase chain reaction (PCR) with the templated plasmid pKD4 and hybrid primers. These primers, P1MdfA (AGCTGCGCTTTATTAAACTCTG CGCGATTA TTATTGGCGAAGAAATTGCGTGTA GGCTGGAGCTGCTTC) and P2MdfA (TCACCATT AATTCGAGAATGCCTGATCGCACAAATCAATCA GGCATTTTTATGGGAATTAGCCATGGTCC), were synthesized with 20 nucleotides (nt) of priming sites 1 and 2 of pKD4 and with 50 nt of the 5\' and 3\' ends of the *mdfA* gene. The 1.6 kb PCR fragment was purified and electroporated into *S flexneri* isolates, 021787 and 021895, into which the red recombinase expression plasmid pKD46 was introduced. Transformants were selected at 37℃ on Luria--Bertani (LB) agar medium containing kanamycin at 50 ug/ml. Homologous recombination between the genomic DNA and the PCR product resulted in the deletion of the *mdfA* sequence from nt --50 to 1327 (1,377-bp deletion) and its replacement with the *kan* gene. This was confirmed by two different PCRs. Deletion of *mdfA* in the transformants was first shown by PCR with primers MdfA3 (GCTGCGCTTTTATTAAACTCTGC) and MdfA4 (CCTGATCGCACAAATCATCA G), whose sequences correspond to sequences flanking the *mdfA* deletion and that resulted in a 1,227-bp fragment for the parental strains and a negative result when *mdfA* was deleted and replaced by the *kan* gene flanked by FLP. The third control PCR, with primers k2 (CGGTGCCCTGAAT GAACTGC) and kt (CGGCCACAGTCGATGAATCC), was used to detect the 471-bp *kan* fragment.

3. Results and Discussion
=========================

The effect of MdfA was confirmed by inactivating the *mdfA* gene located at different chromosomal loci in the strains studied. The antimicrobial susceptibilities of the parent and mutant strains are presented in [Table 1](#T001){ref-type="table"}.Both parent strains were resistant to ciprofloxacin (CIP) at MICs of 16 ug/ml and to NOR at MIC of 32 and 8 ug/ml, respectively. SF021787 and SF021895 were resistant to CIP at MICs of 12 ug/ml and to norprofloxacin (NOR) at MICs of 4 ug/ml regardless of the types of GyrA mutations, which suggests that without a functional MdfA. Compared MICs of the parent with *△mdfA* mutant strains, *△mdfA* mutant strain was more susceptible to CIP and NOR.

Interestingly, the resistance level to fluoroquinolone in the mutant strains harboring the *△mdfA* deletion was the same whether the strains carried three or four mutations in *gyrA*, it because, other efflux system, *acrAB* and *ndeh* contributed to resistance against fluoroquinolone.

The low-level changes in MICs of the *△mdfA* mutant suggest that *mdfA* contributed to the fluoroquinolone resistance in *S flexneri*, but it is not likely to be a major effector for higher resistance levels.
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